search again

Nationwide rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $660,693 · 10th–90th $0$1,445,4400%20%10th90th$660,693Professionalmedian $562,341 · 10th–90th $537,032$676,0830%50%10th90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $954,992.59 / $1,621,810.10
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.03 / $660,693.45
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $707,945.78
Cigna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$645,654.23 / $1,412,537.54 / $1,995,262.31
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $602,559.59 / $676,082.98
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$512,861.38 / $562,341.33 / $851,138.04
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$407,380.28 / $512,861.38 / $831,763.77